Cystic Kidney and Liver Disease Biobank

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 11-002357
    Sponsor Protocol Number: 11-002357

About this study

 

This research study is being done to create a collection of biospecimens (blood, urine, cyst fluid, bile, kidney or liver tissue, etc.) that can be used to facilitate the conduction of research on polycystic kidney and/or liver disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Patients undergoing surgery for polycystic kidney and liver disease or its complications or for a different renal or hepatic disease and wishing to participate in research studies of cystic liver and kidney disease.
  • Patients with polycystic kidney and/or liver disease, undergoing percutaneous cyst aspiration and wishing to participate in research studies of cystic liver and kidney disease.
  • Patients without polycystic kidney or liver disease undergoing nephrectomies or partial hepatectomies for other pathologies.
  • Deceased fetuses with evidence of polycystic kidney and/or liver disease undergoing autopsy
  • Deceased patients with polycystic kidney and/or liver disease undergoing autopsy.

Exclusion Criteria:

  • Individuals who do not comprehend English (i.e., participants must be able to read and sign a consent form without the assistance of an interpreter)
  • Individuals who are unable to sign consent (e.g., mentally challenged, those declared legally incompetent).
  • Individuals regarded as belonging to a vulnerable population (e.g.prisoners).
  • No age exclusion limit.
  • Individuals with HIV or hepatitis infection.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Peter Harris, Ph.D.

Open for enrollment

Contact information:

Charles Madsen CCRP

(507)266-9391

Madsen.Charles@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20315652

Mayo Clinic Footer